APSR2026-47

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-003
P11
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1200172-46904-APSR RSV vaccine_430647.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Wang Chun Kwok * The University of Hong Kong Department of Medicine Hong Kong Hong Kong
Joseph Edgar Blais - The University of Hong Kong Department of Pharmacology and Pharmacy Hong Kong Hong Kong
Qiuyan Liao - The University of Hong Kong Division of Behavioural Sciences, School of Public Health Hong Kong Hong Kong
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Wang Chun
Kwok
kwokwch@hku.hk
+85290915898
Under 30
 
Original Research
Preference for respiratory syncytial virus (RSV) vaccines among older adults with chronic respiratory diseases attending a specialist respiratory medicine clinic: a discrete choice experiment
Maximum 25 words
Abstract Content
While Respiratory syncytial virus (RSV) vaccines are now available, the preferences of older adults with chronic respiratory diseases for RSV vaccination are unknown. Understanding patient preferences for vaccination and the relative effect of contributors to their preferences are critical for evidence-informed development of RSV vaccination programmes.
A discrete choice experiment (DCE) was implemented using survey mode to examine the relative importance of vaccine-related attributes in determining preferences for RSV vaccines among patients aged 60-90 years with chronic respiratory diseases. Participants were recruited from an outpatient respiratory specialist clinic in Hong Kong.
A total of 182 adult patients with chronic respiratory diseases were completed the DCE, with 29.1% consistently choosing the optout option across all 16 choice sets. All five vaccine attributes were significantly associated with preferences for RSV vaccination. Specifically, preferences for vaccination increased with higher vaccine efficacy (β= 0.02 per 1% increase in vaccine efficacy, 95% CI 0.01 – 0.03, p<0.001), a shift from annual to one-time dosing (β= -1.26, 95% CI -1.53 to -0.99, p<0.001), and when the vaccine was recommended by a doctor (β=1.35, 95% CI -1.01 to 1.70, p<0.001; compared to no opinion). Conversely, preferences decreased with a higher probability of vaccine adverse events and increasing vaccination costs (Fig. 1).
Single dose vaccine with higher efficacy, less adverse events, together with recommendation from doctors could all increase patients’ acceptance for a RSV vaccine. These findings could inform policy makers to design the most suitable vaccination strategy for patients with chronic respiratory diseases.
 
 
 
 
 
No
Yes
https://storage.unitedwebnetwork.com/files/1285/1200172-37089-Fig1_363567.jpg
JPG or JPEG or PNG format ONLY
vaccine hesitancy, respiratory syncytial virus vaccine, chronic respiratory disease
maximum 3 keywords and no abbreviations, separated by commas
Nil
259